二次性副甲状腺機能亢進症（Secondary Hyperparathyroidism）：グローバル臨床試験レビュー（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Secondary Hyperparathyroidism 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Secondary Hyperparathyroidism to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Secondary Hyperparathyroidism to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Secondary Hyperparathyroidism 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Secondary Hyperparathyroidism Therapeutics Clinical Trials 31
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Amgen Inc. 34
Clinical Trial Overview of Amgen Inc. 34
AbbVie Inc. 37
Clinical Trial Overview of AbbVie Inc. 37
Sanofi 39
Clinical Trial Overview of Sanofi 39
Abbott Laboratories 41
Clinical Trial Overview of Abbott Laboratories 41
Cytochroma Inc. 42
Clinical Trial Overview of Cytochroma Inc. 42
OPKO Health, Inc. 43
Clinical Trial Overview of OPKO Health, Inc. 43
Astellas Pharma Inc. 44
Clinical Trial Overview of Astellas Pharma Inc. 44
Kirin Holdings Company, Limited 45
Clinical Trial Overview of Kirin Holdings Company, Limited 45
Deltanoid Pharmaceuticals Inc. 46
Clinical Trial Overview of Deltanoid Pharmaceuticals Inc. 46
T-cell Technologies, Inc. 47
Clinical Trial Overview of T-cell Technologies, Inc. 47
Clinical Trial Overview of Top Institutes / Government 48
Centre Hospitalier Universitaire Vaudois 48
Clinical Trial Overview of Centre Hospitalier Universitaire Vaudois 48
Atlanta VA Medical Center 49
Clinical Trial Overview of Atlanta VA Medical Center 49
University of California, Los Angeles 50
Clinical Trial Overview of University of California, Los Angeles 50
Creighton University 51
Clinical Trial Overview of Creighton University 51
Roskilde County Hospital 52
Clinical Trial Overview of Roskilde County Hospital 52
Montefiore Medical Center 53
Clinical Trial Overview of Montefiore Medical Center 53
Indiana University School of Medicine 54
Clinical Trial Overview of Indiana University School of Medicine 54
University of Washington 55
Clinical Trial Overview of University of Washington 55
All India Institute of Medical Sciences 56
Clinical Trial Overview of All India Institute of Medical Sciences 56
Weill Cornell Medical College 57
Clinical Trial Overview of Weill Cornell Medical College 57
Five Key Clinical Profiles 58
Appendix 106
Abbreviations 106
Definitions 106
Research Methodology 107
Secondary Research 107
About GlobalData 108
Contact Us 108
Disclaimer 108
Source 108